Lindsey M. Pieper, Peter Spanogiannopoulos, Regan F. Volk, Carson J. Miller, Aaron T. Wright & Peter J. Turnbaugh. (2023)
The global anaerobic metabolism regulator
fnr
is necessary for the degradation of food dyes and drugs by
Escherichia coli
. mBio 14:5.
Crossref
Sara Mousa, Muhammad Sarfraz & Walaa K. Mousa. (2023) The Interplay between Gut Microbiota and Oral Medications and Its Impact on Advancing Precision Medicine. Metabolites 13:5, pages 674.
Crossref
Patrick H. Bradley. (2023) Four-part harmony between diet, drugs, microbes, and host. Cell Host & Microbe 31:5, pages 689-691.
Crossref
Janni Støvring Mortensen, Duc Ninh Nguyen, Hanne Mørck Nielsen & Stine Rønholt. (2023) Effects of prophylactic antibiotics administration on barrier properties of intestinal mucosa and mucus from preterm born piglets. Drug Delivery and Translational Research 13:5, pages 1456-1469.
Crossref
Aneela Gulnaz, Ji-Eun Chang, Han-Joo Maeng, Kwang-Hee Shin, Kyeong-Ryoon Lee & Yoon-Jee Chae. (2022) A mechanism-based understanding of altered drug pharmacokinetics by gut microbiota. Journal of Pharmaceutical Investigation 53:1, pages 73-92.
Crossref
Muhammad Suleman Tahir, Muhammad Sagir & Muhammad Bilal TahirMuhammad Suleman Tahir, Muhammad Sagir & Muhammad Bilal Tahir. 2023. Advances in Water and Wastewater Treatment Technology. Advances in Water and Wastewater Treatment Technology
15
33
.
Omnia Azmy Nabeh. (2022) Gut microbiota and cardiac arrhythmia: a pharmacokinetic scope. The Egyptian Heart Journal 74:1.
Crossref
Mezna Saleh Altowyan, Saied M. Soliman, Magda M. F. Ismail, Matti Haukka, Assem Barakat & Mohammed Salah Ayoup. (2022) New Bioprecursor Prodrugs of Sulfadiazine: Synthesis, X-ray Structure and Hirshfeld Analysis. Crystals 12:8, pages 1016.
Crossref
Keiya Hirosawa, Tatsuki Fukami, Mai Nagaoka, Masataka Nakano & Miki Nakajima. (2022) Methionine Sulfoxide Reductase A in Human and Mouse Tissues is Responsible for Sulindac Activation, Making a Larger Contribution than the Gut Microbiota. Drug Metabolism and Disposition 50:5, pages 725-733.
Crossref
Pooja Dhurjad, Chinmayi Dhavaliker, Kajal Gupta & Rajesh Sonti. (2022) Exploring Drug Metabolism by the Gut Microbiota: Modes of Metabolism and Experimental Approaches. Drug Metabolism and Disposition 50:3, pages 224-234.
Crossref
Tanshi Mehrotra & Subir Kumar Maulik. 2022. Human Microbiome in Health and Disease - Part A. Human Microbiome in Health and Disease - Part A
207
228
.
Suryanarayana Polaka, Hari Priya Koppisetti, Muktika Tekade, Mukesh Chandra Sharma, Pinaki Sengupta & Rakesh Kumar Tekade. 2022. Pharmacokinetics and Toxicokinetic Considerations. Pharmacokinetics and Toxicokinetic Considerations
291
322
.
Aqsa Shahid, Sumreen Hayat, Samman Munir, Usman Ali Ashfaq, Abdul Arif Khan, Muhammad Bilal, Irfan Shaukat & Mohsin Khurshid. 2022. Biochemistry of Drug Metabolizing Enzymes. Biochemistry of Drug Metabolizing Enzymes
375
397
.
Susannah Selber-Hnatiw. 2022. Comprehensive Gut Microbiota. Comprehensive Gut Microbiota
46
68
.
Sara A. Zahran, Marwa Ali-Tammam, Amal E. Ali & Ramy K. Aziz. (2021) Compositional variation of the human fecal microbiome in relation to azo-reducing activity: a pilot study. Gut Pathogens 13:1.
Crossref
Lavinia Curini & Amedeo Amedei. (2021) Cardiovascular Diseases and Pharmacomicrobiomics: A Perspective on Possible Treatment Relevance. Biomedicines 9:10, pages 1338.
Crossref
Xintong Zhang, Ying Han, Wei Huang, Mingji Jin & Zhonggao Gao. (2021) The influence of the gut microbiota on the bioavailability of oral drugs. Acta Pharmaceutica Sinica B 11:7, pages 1789-1812.
Crossref
Aishwarya Naik & Santosh K. Misra. (2021) Modern Sensing Approaches for Predicting Toxicological Responses of Food- and Drug-Based Bioactives on Microbiomes of Gut Origin. Journal of Agricultural and Food Chemistry 69:23, pages 6396-6413.
Crossref
Jie Jack Li. 2020. Medicinal Chemistry for Practitioners. Medicinal Chemistry for Practitioners
133
224
.
Chaonan Sun, Ling Chen & Zhu Shen. (2019) Mechanisms of gastrointestinal microflora on drug metabolism in clinical practice. Saudi Pharmaceutical Journal 27:8, pages 1146-1156.
Crossref
Yuhua Li, Qiang Meng, Mengbi Yang, Dongyang Liu, Xiangyu Hou, Lan Tang, Xin Wang, Yuanfeng Lyu, Xiaoyan Chen, Kexin Liu, Ai-Ming Yu, Zhong Zuo & Huichang Bi. (2019) Current trends in drug metabolism and pharmacokinetics. Acta Pharmaceutica Sinica B 9:6, pages 1113-1144.
Crossref
Jason M. Koontz, Blair C. R. Dancy, Cassandra L. Horton, Jonathan D. Stallings, Valerie T. DiVito & John A. Lewis. (2019) The Role of the Human Microbiome in Chemical Toxicity. International Journal of Toxicology 38:4, pages 251-264.
Crossref
Ana V. Cheng & William M. Wuest. (2019) Signed, Sealed, Delivered: Conjugate and Prodrug Strategies as Targeted Delivery Vectors for Antibiotics. ACS Infectious Diseases 5:6, pages 816-828.
Crossref
Juanhong Zhang, Junmin Zhang, Rong Wang & Zhengping Jia. (2019) Effects of Gut Microbiota on Drug Metabolism and Guidance for Rational Drug Use Under Hypoxic Conditions at High Altitudes. Current Drug Metabolism 20:2, pages 155-165.
Crossref
Atanu Adak & Mojibur R. Khan. (2018) An insight into gut microbiota and its functionalities. Cellular and Molecular Life Sciences 76:3, pages 473-493.
Crossref
Min Sun Choi, Jun Sang Yu, Hye Hyun Yoo & Dong-Hyun Kim. (2018) The role of gut microbiota in the pharmacokinetics of antihypertensive drugs. Pharmacological Research 130, pages 164-171.
Crossref
L. Chi & K. Lu. 2018. Comprehensive Toxicology. Comprehensive Toxicology
59
73
.
Ali Ryan. (2016) Azoreductases in drug metabolism. British Journal of Pharmacology 174:14, pages 2161-2173.
Crossref
Ian D. Wilson & Jeremy K. Nicholson. (2017) Gut microbiome interactions with drug metabolism, efficacy, and toxicity. Translational Research 179, pages 204-222.
Crossref
Robert G. Nichols, Nicole E. Hume, Philip B. Smith, Jeffrey M. Peters & Andrew D. Patterson. (2016) Omics Approaches To Probe Microbiota and Drug Metabolism Interactions. Chemical Research in Toxicology 29:12, pages 1987-1997.
Crossref
Lenka Jourova, Pavel Anzenbacher & Eva Anzenbacherova. (2016) Human gut microbiota plays a role in the metabolism of drugs. Biomedical Papers 160:3, pages 317-326.
Crossref
Dong-Hyun Kim. (2015) Gut Microbiota-Mediated Drug-Antibiotic Interactions. Drug Metabolism and Disposition 43:10, pages 1581-1589.
Crossref
Lian Yee Yip & Eric Chun Yong Chan. (2015) Investigation of Host–Gut Microbiota Modulation of Therapeutic Outcome. Drug Metabolism and Disposition 43:10, pages 1619-1631.
Crossref
F. Akarslan & H. Demiralay. (2015) Effects of Textile Materials Harmful to Human Health. Acta Physica Polonica A 128:2B, pages B-407-B-409.
Crossref
Ian D. Wilson & Jeremy K. Nicholson. 2015. Metabonomics and Gut Microbiota in Nutrition and Disease. Metabonomics and Gut Microbiota in Nutrition and Disease
323
341
.
Henry J. Haiser & Peter J. Turnbaugh. (2013) Developing a metagenomic view of xenobiotic metabolism. Pharmacological Research 69:1, pages 21-31.
Crossref
Caroline H. Johnson & Frank J. Gonzalez. (2012) Challenges and opportunities of metabolomics. Journal of Cellular Physiology 227:8, pages 2975-2981.
Crossref
Shigeyuki Kitamura, Kazumi Sugihara, Mie Kuwasako & Kiyoshi Tatsumi. (1997) The Role of Mammalian Intestinal Bacteria in the Reductive Metabolism of Zonisamide. Journal of Pharmacy and Pharmacology 49:3, pages 253-256.
Crossref
Junzo Nakamura, Chieko Tagami, Koyo Nishida & Hitoshi Sasaki. (1992)
Development of a Prodrug of Salicylic Acid, Salicylic Acid-
l
-alanine Conjugate, Utilizing Hydrolysis by Rabbit Intestinal Microorganisms
. Journal of Pharmacy and Pharmacology 44:4, pages 295-299.
Crossref
Shigeyuki Kitamura, Mie Kuwasako, Shigeru Ohta & Kiyoshi Tatsumi. (1999) Reductive Debromination of (α-Bromoiso-valeryl)urea by Intestinal Bacteria. Journal of Pharmacy and Pharmacology 51:1, pages 79-84.
Crossref
Ralph Gingell & Andrew Renwick. (2008) Rebuttal to Letter to the Editor. Regulatory Toxicology and Pharmacology 52:3, pages 352.
Crossref
Tiago Sousa, Ronnie Paterson, Vanessa Moore, Anders Carlsson, Bertil Abrahamsson & Abdul W. Basit. (2008) The gastrointestinal microbiota as a site for the biotransformation of drugs. International Journal of Pharmaceutics 363:1-2, pages 1-25.
Crossref
Rodrigo Otávio Alves de Lima, Ana Paula Bazo, Daisy Maria Fávero Salvadori, Célia Maria Rech, Danielle de Palma Oliveira & Gisela de Aragão Umbuzeiro. (2007) Mutagenic and carcinogenic potential of a textile azo dye processing plant effluent that impacts a drinking water source. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 626:1-2, pages 53-60.
Crossref
Jeremy K. Nicholson, Elaine Holmes & John C. Lindon. 2007. The Handbook of Metabonomics and Metabolomics. The Handbook of Metabonomics and Metabolomics
1
33
.
KEVIN J. DUFFY & CONNIE L. ERICKSON-MILLER. 2007. Target Validation in Drug Discovery. Target Validation in Drug Discovery
241
254
.
Alexis Nzila. (2006) Inhibitors of de novo folate enzymes in Plasmodium falciparum. Drug Discovery Today 11:19-20, pages 939-944.
Crossref
Jeremy K Nicholson, Elaine Holmes, John C Lindon & Ian D Wilson. (2004) The challenges of modeling mammalian biocomplexity. Nature Biotechnology 22:10, pages 1268-1274.
Crossref
Shuji Tsuda, Naonori Matsusaka, Hiroo Madarame, Shunji Ueno, Nobuyuki Susa, Kumiko Ishida, Noriko Kawamura, Kaoru Sekihashi & Yu F Sasaki. (2000) The comet assay in eight mouse organs: results with 24 azo compounds. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 465:1-2, pages 11-26.
Crossref
AP Moghaddam, R. Abbas, JW Fisher & JC Lipscomb. (2016) The role of mouse intestinal microflora in the metabolism of trichloroethylene, an in vivo study. Human & Experimental Toxicology 16:11, pages 629-635.
Crossref
M. Mikov. (1994) The metabolism of drugs by the gut flora. European Journal of Drug Metabolism and Pharmacokinetics 19:3, pages 201-207.
Crossref
Junzo Nakamura, Mitsuhiko Kido, Chieko Tagami, Koyo Nishida & Hitoshi Sasaki. (1993) Systemic and presystemic de-conjugation of salicylic acid-arginine conjugate as a prodrug of salicylic acid in rabbits. International Journal of Pharmaceutics 99:2-3, pages 189-195.
Crossref
M.Abu Shamat. (1993) The role of the gastrointestinal microflora in the metabolism of drugs. International Journal of Pharmaceutics 97:1-3, pages 1-13.
Crossref
Satoshi Takeno & Takeshi Sakai. (2005) Involvement of the intestinal microflora in nitrazepam‐induced teratogenicity in rats and its relationship to nitroreduction. Teratology 44:2, pages 209-214.
Crossref
G.L. LARSEN. 1988. Role of the Gut Flora in Toxicity and Cancer. Role of the Gut Flora in Toxicity and Cancer
79
107
.
M.E. COATES, B.S. DRASAR, A.K. MALLETT & I.R. ROWLAND. 1988. Role of the Gut Flora in Toxicity and Cancer. Role of the Gut Flora in Toxicity and Cancer
1
21
.
R.W. Schaedler & R.P. Orcutt. 1983. The Mouse in Biomedical Research. The Mouse in Biomedical Research
327
345
.
David M. Conning & A. B. G. LansdownI. R. Rowland & R. Walker. 1983. Toxic Hazards in Food. Toxic Hazards in Food
183
274
.
Andrew G. Renwick, Susan P. Evans, Trevor W. Sweatman, Janet Cumberland & Charles F. George. (1982) The role of the gut flora in the reduction of sulphinpyrazone in the rat. Biochemical Pharmacology 31:16, pages 2649-2656.
Crossref
Michael J. Prival & Valerie D. Mitchell. (1982) Analysis of a method for testing azo dyes for mutagenic activity in Salmonella typhimurium in the presence of flavin mononucleotide and hamster liver S9. Mutation Research/Environmental Mutagenesis and Related Subjects 97:2, pages 103-116.
Crossref
A.G. Renwick. 1982. Presystemic Drug Elimination. Presystemic Drug Elimination
3
28
.
PETER GOLDMAN. 1982. Metabolic Basis of Detoxication. Metabolic Basis of Detoxication
323
337
.
D.S. HEWICK. 1982. Metabolic Basis of Detoxication. Metabolic Basis of Detoxication
151
170
.
Stephen C. Mitchell & Rosemary H. Waring. (2006) The metabolism of benodanil in the rat. Pesticide Science 12:1, pages 79-85.
Crossref
Michael R. Boyd, Ann W. Stiko & Henry A. Sasame. (1979) Metabolic activation of nitrofurantoin—possible implications for carcinogenesis. Biochemical Pharmacology 28:5, pages 601-606.
Crossref
L. A. Griffiths & V. Facchini. 1979. Recent Developments in Mass Spectrometry in Biochemistry and Medicine. Recent Developments in Mass Spectrometry in Biochemistry and Medicine
121
126
.
G. C. Bolton & L. A. Griffiths. (1978) Metabolism of hydrazines and hydrazides by the intestinal microflora. Experientia 34:11, pages 1484-1486.
Crossref
Stephen C. Mitchell & Rosemary H. Waring. (2006)
The metabolism of
cis
‐2,5‐dimethylpyrrolidine‐1‐carboxanilide in rodents
. Pesticide Science 9:5, pages 393-401.
Crossref
K. Sandy Pang & James R. Gillette. (1978) Theoretical Relationships between Area under the Curve and Route of Administration of Drugs and Their Precursors for Evaluating Sites and Pathways of Metabolism. Journal of Pharmaceutical Sciences 67:5, pages 703-704.
Crossref
Alan Warrander & Rosemary H. Waring. (2006) The metabolism of mebenil in rats, rabbits and guinea‐pigs. Pesticide Science 8:1, pages 54-58.
Crossref
B.G. Reddy, L.R. Pohl & G. Krishna. (1976) The requirement of the gut flora in nitrobenzene-induced methemoglobinemia in rats. Biochemical Pharmacology 25:9, pages 1119-1122.
Crossref
I.B. ELTAYEB & O.H. OSMAN. (2012) FURAZOLIDONE‐PETHIDINE INTERACTION IN RABBITS. British Journal of Pharmacology 55:4, pages 497-501.
Crossref
J. H. Weisburger & G. M. Williams. 1975. Cancer. A Comprehensive Treatise. Cancer. A Comprehensive Treatise
185
234
.